Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Trials|May 10, 2023
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trialBrett J Manley, C Omar F Kamlin, Susan Donath, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson diseasePeter Ott, Thomas Sandahl, Aftab Ala, et al.
The Lancet. Gastroenterology & Hepatology|October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trialMichael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
JHEP Reports : Innovation in Hepatology|August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targetsPeter Ott, Thomas Sandahl, Aftab Ala, et al.
Resuscitation|July 24, 2021
A multi-centre randomised controlled trial of respiratory function monitoring during stabilisation of very preterm infants at birthHenriëtte A van Zanten, Kristel L A M Kuypers, Erik W van Zwet, et al.
Nature Communications|November 14, 2020
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunitiesSteven X Cho, Ina Rudloff, Jason C Lao, et al.
Science Translational Medicine|April 6, 2022
Type 2 immune polarization is associated with cardiopulmonary disease in preterm infantsJason C Lao, Christine B Bui, Merrin A Pang, et al.
JAMA|November 11, 2024
Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants: The PLUSS Randomized Clinical TrialBrett J Manley, C Omar F Kamlin, Susan M Donath, et al.
JAMA|December 13, 2021
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
JAMA|September 11, 2023
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical TrialPeter A Dargaville, C Omar F Kamlin, Francesca Orsini, et al.
Pageof 9